GENFIT S.A Revenue 2019-2022 | GNFT
GENFIT S.A revenue from 2019 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
GENFIT S.A Annual Revenue
(Millions of US $) |
| 2021 |
$101 |
| 2020 |
$9 |
| 2019 |
$46 |
| 2018 |
$9 |
GENFIT S.A Quarterly Revenue
(Millions of US $) |
| 2022-06-30 |
|
| 2021-12-31 |
|
| 2021-06-30 |
|
| 2020-12-31 |
|
| 2020-06-30 |
|
| 2019-12-31 |
|
| 2019-06-30 |
|
| 2018-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.208B |
$0.101B |
|
Genfit SA is a biopharmaceutical company. It focuses on the discovery and development of therapeutic and diagnostic solutions in metabolic and liver related diseases. The company's lead products include Elafibranor, Nitazoxanide and TGFTX1 which are in clinical stage. Genfit SA is based in Loos, France.
|
